Related Experiment Video
Updated: Apr 27, 2026

Oral Biofilm Formation on Different Materials for Dental Implants
Published on: June 24, 2018
Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen
Yvonne Achermann1, Ellie J C Goldstein2, Tom Coenye3
1Department of Microbial Pathogenesis, Dental School, University of Maryland, Baltimore, Maryland, USA.
Abstract:
Propionibacterium acnes is known primarily as a skin commensal. However, it can present as an opportunistic pathogen via bacterial seeding to cause invasive infections such as implant-associated infections. These infections have gained more attention due to improved diagnostic procedures, such as sonication of explanted foreign materials and prolonged cultivation time of up to 14 days for periprosthetic biopsy specimens, and improved molecular methods, such as broad-range 16S rRNA gene PCR. Implant-associated infections caused by P. acnes are most often described for shoulder prosthetic joint infections as well as cerebrovascular shunt infections, fibrosis of breast implants, and infections of cardiovascular devices. P. acnes causes disease through a number of virulence factors, such as biofilm formation. P. acnes is highly susceptible to a wide range of antibiotics, including beta-lactams, quinolones, clindamycin, and rifampin, although resistance to clindamycin is increasing. Treatment requires a combination of surgery and a prolonged antibiotic treatment regimen to successfully eliminate the remaining bacteria. Most authors suggest a course of 3 to 6 months of antibiotic treatment, including 2 to 6 weeks of intravenous treatment with a beta-lactam. While recently reported data showed a good efficacy of rifampin against P. acnes biofilms, prospective, randomized, controlled studies are needed to confirm evidence for combination treatment with rifampin, as has been performed for staphylococcal implant-associated infections.
Insights
Propionibacterium acnes, typically a skin bacterium, can cause serious implant-associated infections. Effective treatment involves surgery and long-term antibiotics, with rifampin showing promise against biofilms.
Area of Science:
- Microbiology
- Infectious Diseases
- Biomedical Engineering
Background:
- Propionibacterium acnes (P. acnes) is recognized as a skin commensal but can act as an opportunistic pathogen.
- Improved diagnostics, including sonication and extended cultivation, have increased the detection of P. acnes in invasive infections.
- P. acnes is implicated in various implant-associated infections, notably shoulder prosthetics, cerebrovascular shunts, breast implants, and cardiovascular devices.
Purpose of the Study:
- To review the role of P. acnes as an opportunistic pathogen in implant-associated infections.
- To discuss diagnostic advancements for P. acnes detection.
- To summarize current and potential therapeutic strategies for P. acnes infections.
Main Methods:
- Literature review of P. acnes as a pathogen in implant-associated infections.
- Analysis of diagnostic techniques, including sonication and molecular methods (16S rRNA gene PCR).
- Evaluation of antibiotic susceptibility and treatment regimens, including biofilm efficacy.
Main Results:
- P. acnes infections are increasingly recognized in orthopedic, neurosurgical, and cardiovascular implants.
- Biofilm formation is a key virulence factor for P. acnes.
- P. acnes is generally susceptible to antibiotics like beta-lactams, quinolones, and rifampin, though clindamycin resistance is rising.
Conclusions:
- Implant-associated infections caused by P. acnes necessitate a combined surgical and prolonged antibiotic approach.
- Rifampin demonstrates efficacy against P. acnes biofilms, suggesting potential for combination therapy.
- Further randomized controlled trials are needed to establish optimal combination antibiotic regimens, particularly involving rifampin.
More Related Videos
Related Concept Videos
Biofilms
The Skin Microbiota
Acne Infection
Bacterial Signaling
The Oral Microbiota
Colonisation of Pathogens

